LavaTM Liquid Embolization Agent yog ua los ntawm cov khoom tsis-nplaum.Qhov sib txawv Lava formulations muaj pub rau xaiv cov viscosities tsim nyog nyob ntawm seb qhov loj thiab cov ntshav ntws npaum li cas hauv vasculature tsom. Piv txwv li, qis viscosity versions Lava-12 nta tshwj xeeb embolic zog uas txawv heev ntawm cov neeg sib tw. Vim nws qis viscosity, Lava-12 tuaj yeem ua kom nrawm dua thiab ntev dua antegrade ntws ntawm LEA thaum lub sij hawm embolization, thiab raws li ua rau kom nrawm dua thiab zoo dua nkag mus rau lub hom phiaj vasculature.Whereas, Lava-18 yog qhov zoo dua rau kev kho mob ntawm endoleaks qhov twg ntau dua viscosity ntawm Lava-18 yog qhov zoo dua tuaj yeem tiv thaiv los ntawm cov ntshav ntws. LavaTM yuav tsum tau txhaj los ntawm DMSO-tshaj microcatheter. DMSO cov kuab tshuaj dissipates rau hauv cov ntshav, ua rau EVOH copolymer thiab tshem tawm tantalum los precipitate nyob rau hauv situ rau hauv ib tug spongy, coherent embolus.
Nta & Qhov Zoo
1. Nws tau ua los ntawm cov khoom tsis yog nplaum thiab siv cov cuab yeej tshiab ntawm EVOH co-polymer.
2. Nws muab cov kws kho mob muaj peev xwm nthuav dav lawv txoj kev kho mob nrog Lava 12, Lava 18 thiab Lava 34.
3. Cov viscosity qis dua ua kom cov kua dej ntau dua kom tso cai rau kev nkag mus tob rau hauv nidus thiab ncav cuag cov microvessels distal thiab txhaj los ntawm cov khoom me me.
4. Ib qho ruaj khov thiab tswj kev txhaj tshuaj thiab xa mus kom ncav cuag lub hom phiaj embolism.
5. Qhov me me ntawm micronized tantalum hmoov lub hom phiaj los txhim kho cov homogeneity hauv radiopacity thiab txhim kho qhov pom kev thaum lub sij hawm txhaj tshuaj ntev dua.
Txhua cov khoom siv LavaMuaj:
Ib 1.5 ml vial ntawm Lava -18
1.5 ml ntawm DMSO
Ib 1 ml xiav syringe rau DMSO
Ob 1 ml dawb syringes rau Lava
Specifications
FAQ
Q1. Vim li cas LAVA tuaj yeem ua raws li embolism?
A1. EVOH yog dej-insoluble tab sis soluble hauv DMSO. Thaum nyob rau hauv kev sib cuag nrog ib tug aqueous tov (xws li ntshav), DMSO 's sai sai diffuses mus rau hauv lub aqueous tov, thiab EVOH precipitates rau hauv ib tug khoom ua si lub luag hauj lwm embolism.
Q2. Vim li cas LAVA tuaj yeem pom kev nyob hauv hluav taws xob?
A2. EVOH nws tus kheej tsis pom kev nyob rau hauv hluav taws xob, thiab tshem tawm micronized lis loj Tantaum hmoov muab nws cov xov tooj cua
Q3. LAVA muaj pes tsawg formulations qauv?
A3. Raws li qhov concentration, LAVA tuaj yeem muab faib ua peb hom qauv: LAVA-12, LAVA-18 thiab LAVA-34.
Q4. Dab tsi yog cov qauv sib txawv haum rau?
A4. Thawj ob qhov qis-viscosity LAVA formulations yog tsim rau embolization ntawm arteriovenous malformations, qhov twg cov hlab ntsha yog nyias thiab yuav tsum tau nkag mus rau tob kom ua tau zoo embolization. Thaum Lava-34 feem ntau yog siv rau siab embolization ntws hlab ntsha.
